Select your timezone:

State-of-the-Art Session
Multidisciplinary approach in transplant oncology - expanding liver transplantation for cancer: call in the multidisciplinary troops

Wednesday September 14, 2022 | 16:00 to 17:30
Room: D
Track: Liver

Video is available - Log in to view. You must be registered to the event to view content

Description

For attending this session, you can claim 1.5 EACCME credits

Learning Objectives

After this session, the attendees should be able to:
- Discuss historical outcomes in patients undergoing liver transplantation for intrahepatic cholangiocarcinoma and metastatic neuroendocrine cancer and risk factors associated with poorer outcomes
- Examine new concepts in the use of neoadjuvant therapy, optimizing staging, timing and management of patients with intrahepatic cholangiocarcinoma and metastatic neuroendocrine tumors to the liver in consideration for liver transplantation
- Understand the use of cell free DNA in managing patients with HCC before and after liver transplantation for hepatocellular carcinoma

Presentations

Prof. Andrea Frilling, United Kingdom
What are the limits for neuroendocrine tumors?

Dr. Gonzalo Sapisochin, Canada
Strategies to minimize the risk of recurrence of cholangiocarcinona (iCCA)

Dr. Juliet Emamaullee, United States
Cell free DNA in the diagnosis of HCC

© 2022 TTS 2022